FDA Expected To Approve New, Gentler Cure For Hepatitis C
The first in a new class of drugs that can cure the viral infection that is the leading cause of liver failure and liver cancer is poised for a marketing green light from the Food and Drug Administration. More than 3 million Americans have hepatitis C, but most don't know it.